Burden, Access, and Disparities in Kidney Disease

Canadian Journal of Kidney Health and Disease

Volumn 6, Issue , 2019, Pages

  Crews, Deidra C ^a,b,c   Bello, Aminu K ^d   Saadi, Gamal ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

acute kidney injury; end stage renal disease; global health; health equity; social determinants of health

Indexed keywords

APOLIPOPROTEIN L1; CREATININE;

ACUTE KIDNEY FAILURE; AWARENESS; CHRONIC KIDNEY FAILURE; CULTURAL FACTOR; DIABETES MELLITUS; DISEASE BURDEN; DISEASE SURVEILLANCE; EDITORIAL; END STAGE RENAL DISEASE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH DISPARITY; HEALTH EQUITY; HEALTH INSURANCE; HEALTH SERVICE; HEALTH WORKFORCE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; NEPHROLOGY; PERITONEAL DIALYSIS; POLITICS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH; RENAL REPLACEMENT THERAPY; SOCIOECONOMICS; URINALYSIS; VASCULAR ACCESS;

EID: 85068539355     PISSN: None     EISSN: 20543581     Source Type: Journal    
DOI: 10.1177/2054358119836124     Document Type: Editorial

References (48)

1. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603-1658. doi:10.1016/S0140-6736(16)31460-X.
2. Hill NR, Fatoba ST, Oke JL. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS ONE. 2016;11:e0158765.
3. Crews DC, Liu Y, Boulware LE., Disparities in the burden, outcomes, and care of chronic kidney disease. Curr Opin Nephrol Hypertens. 2014;23(3):298-305. doi:10.1097/01.mnh.0000444822.25991.f6.
4. Bello AK, Levin A, Tonelli M. Global Kidney Health Atlas: a report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. https://www.theisn.org/images/ISN_advocacy/GKHAtlas_Linked_Compressed1.pdf. Published 2017. Accessed August 22, 2018.
5. Stanifer JW, Jing B, Tolan S. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174-e181. doi:10.1016/S2214-109X(14)70002-6.
6. Davids MR, Eastwood JB, Selwood NH. A renal registry for Africa: first steps. Clin Kidney J. 2016;9(1):162-167. doi:10.1093/ckj/sfv122.
7. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544. doi:10.1016/S0140-6736(16)31012-1.
8. Liyanage T, Ninomiya T, Jha V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975-1982. doi:10.1016/S0140-6736(14)61601-9.
9. Mehta RL, Cerda J, Burdmann EA. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987):2616-2643. doi:10.1016/S0140-6736(15)60126-X.
10. Samuel SM, Palacios-Derflingher L, Tonelli M. Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuria. CMAJ. 2014;186(2):E86-E94. doi:10.1503/cmaj.130776.
11. Nicholas SB, Kalantar-Zadeh K, Norris KC., Racial disparities in kidney disease outcomes. Semin Nephrol. 2013;33:409-415.
12. van den Beukel TO, de Goeij MC, Dekker FW, Siegert CE, Halbesma N,; PREPARE Study Group. Differences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system. Clin J Am Soc Nephrol. 2013;8(9):1540-1547. doi:10.2215/CJN.10761012.
13. Crews DC, Gutierrez OM, Fedewa SA. Low income, community poverty and risk of end stage renal disease. BMC Nephrol. 2014;15:192. doi:10.1186/1471-2369-15-192.
14. Garrity BH, Kramer H, Vellanki K, Leehey D, Brown J, Shoham DA., Time trends in the association of ESRD incidence with area-level poverty in the US population. Hemodial Int. 2016;20(1):78-83. doi:10.1111/hdi.12325.
15. Parsa A, Kao WH, Xie D. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183-2196. doi:10.1056/NEJMoa1310345.
16. Peralta CA, Bibbins-Domingo K, Vittinghoff E. APOL1 genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2016;27(3):887-893. doi:10.1681/ASN.2015020124.
17. Correa-Rotter R. Mesoamerican nephropathy or chronic kidney disease of unknown origin. In: García-García G, Agodoa LY, Norris KC, eds. Chronic Kidney Disease in Disadvantaged Populations. Cambridge, MA: Academic Press; 2017:221-228.
18. Levin A, Stevens PE, Bilous RW. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
19. Chan JC, Gregg EW, Sargent J, Horton R., Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission. Lancet. 2016;387(10027):1494-1495. doi:10.1016/S0140-6736(16)30165-9.
20. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J., Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-223. doi:10.1016/S0140-6736(05)17741-1.
21. Plantinga LC, Miller ER, IIIStevens LA. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension. 2009;54(1):47-56. doi:10.1161/HYPERTENSIONAHA.109.129841.
22. Banerjee T, Liu Y, Crews DC., Dietary patterns and CKD progression. Blood Purif. 2016;41:117-122.
23. Johnson AE, Boulware LE, Anderson CA. Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study. BMC Nephrol. 2014;15:194. doi:10.1186/1471-2369-15-194.
24. Crews DC, Kuczmarski MF, Miller ER, IIIZonderman AB, Evans MK, Powe NR., Dietary habits, poverty, and chronic kidney disease in an urban population. J Ren Nutr. 2015;25(2):103-110. doi:10.1053/j.jrn.2014.07.008.
25. Suarez JJ, Isakova T, Anderson CA, Boulware LE, Wolf M, Scialla JJ. Food access, chronic kidney disease, and hypertension in the U.S. Am J Prev Med. 2015;49(6):912-920. doi:10.1016/j.amepre.2015.07.017.
26. Crews DC, Kuczmarski MF, Grubbs V. Effect of food insecurity on chronic kidney disease in lower-income Americans. Am J Nephrol. 2014;39(1):27-35. doi:10.1159/000357595.
27. Banerjee T, Crews DC, Wesson DE. Food insecurity, CKD, and subsequent ESRD in US adults. Am J Kidney Dis. 2017;70:38-47.
28. Piccoli GB, Alrukhaimi M, Liu ZH. Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int. 2018;93:278-283.
29. Food and Agriculture Organization of the United Nations. The FAO hunger map 2015. http://www.fao.org/3/a-i4674e.pdf. Published 2015. Accessed August 22, 2018.
30. Shariff ZM, Khor GL., Obesity and household food insecurity: evidence from a sample of rural households in Malaysia. Eur J Clin Nutr. 2005;59(9):1049-1058. doi:10.1038/sj.ejcn.1602210.
31. Popkin BM., Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc. 2011;70(1):82-91. doi:10.1017/S0029665110003903.
32. Sawhney S, Marks A, Fluck N, Levin A, Prescott G, Black C., Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69(1):18-28. doi:10.1053/j.ajkd.2016.05.018.
33. Heung M, Steffick DE, Zivin K. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration data. Am J Kidney Dis. 2016;67(5):742-752. doi:10.1053/j.ajkd.2015.10.019.
34. Grams ME, Matsushita K, Sang Y. Explaining the racial difference in AKI incidence. J Am Soc Nephrol. 2014;25(8):1834-1841. doi:10.1681/ASN.2013080867.
35. Luyckx VA, Tuttle KR, Garcia-Garcia G. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl. 2017;7(2):71-87. doi:10.1016/j.kisu.2017.07.003.
36. Lewington AJ, Cerda J, Mehta RL., Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013;84(3):457-467. doi:10.1038/ki.2013.153.
37. Cervantes L, Tuot D, Raghavan R. Association of emergency-only vs standard hemodialysis with mortality and health care use among undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2018;178(2):188-195. doi:10.1001/jamainternmed.2017.7039.
38. Rizvi SA, Naqvi SA, Zafar MN, Akhtar SF., A kidney transplantation model in a low-resource country: an experience from Pakistan. Kidney Int Suppl. 2013;3(2):236-240. doi:10.1038/kisup.2013.22.
39. Roberti J, Cummings A, Myall M. Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies. BMJ Open. 2018;8(9):e023507. doi:10.1136/bmjopen-2018-023507.
40. Kierans C, Padilla-Altamira C, Garcia-Garcia G, Ibarra-Hernandez M, Mercado FJ., When health systems are barriers to health care: challenges faced by uninsured Mexican kidney patients. PLoS ONE. 2013;8(1):e54380. doi:10.1371/journal.pone.0054380.
41. Murray CJ, Frenk J., A framework for assessing the performance of health systems. Bull World Health Organ. 2000;78:717-731.
42. Htay H, Alrukhaimi M, Ashuntantang GE. Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. Kidney Int Suppl. 2018;8(2):64-73. doi:10.1016/j.kisu.2017.10.010.
43. Osman MA, Alrukhaimi M, Ashuntantang GE. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8(2):52-63. doi:10.1016/j.kisu.2017.10.009.
44. World Health Organization. Global Health Observatory indicator views. http://apps.who.int/gho/data/node.imr#ndx-P. Accessed August 22, 2018.
45. Harris DC, Dupuis S, Couser WG, Feehally J., Training nephrologists from developing countries: does it have a positive impact? Kidney Int Suppl. 2012;2(3):275-278. doi:10.1038/kisup.2012.32.
46. Couser WG, Remuzzi G, Mendis S, Tonelli M., The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80:1258-1270.
47. Chionh CY, Soni SS, Finkelstein FO, Ronco C, Cruz DN., Use of peritoneal dialysis in AKI: a systematic review. Clin J Am Soc Nephrol. 2013;8(10):1649-1660. doi:10.2215/CJN.01540213.
48. Muralidharan A, White S., The need for kidney transplantation in low- and middle-income countries in 2012: an epidemiological perspective. Transplantation. 2015;99(3):476-481. doi:10.1097/TP.0000000000000657.